MetaCap

Vir Biotechnology Statistics

NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.39-0.48 (-5.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vir Biotechnology by the numbers

Vir Biotechnology has a market capitalization of $1.56 billion based on 186.27M shares outstanding. With trailing EPS of $-1.18, Vir Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 14.4% below its 200-day average.

Average daily trading volume is 2.45M shares, or about $20.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VIR valuation vs. peer median

VIR compared with the median of 8 peer companies
MetricVIRPeer medianDifference
Market cap$1.56B$1.50B+4%
Avg. volume2.45M594.01K+313%

Peer median across 8 companies: RXRX, ALVO, WWB, MESO, MAZE, LYCA, IMCR, REPL.

Valuation

Price / sales (latest FY)
22.80
EPS (TTM)
$-1.18

Price and trading

Previous close
8.87
Open
8.81
Day range
8.34 – 8.92
52-week range
5.45 – 14.38
52-week change
+47.71%
Beta
—
Volume
3.09M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.56B
Forward Pe
-3.51
Eps
-1.18
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.38
Week52 Low
5.45
Avg Volume
2.45M
Shares Outstanding
186.27M
Ma50
10.96
Ma200
9.80
Earnings Date
Nov 4, 2026
Pct From52w High
-41.66%
Pct From52w Low
53.94%

Related